213 related articles for article (PubMed ID: 6255477)
1. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
Cheng YC; Chen JY; Glaser R; Henle W
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
Henle G; Henle W
Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
[TBL] [Abstract][Full Text] [Related]
3. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins.
Littler E; Baylis SA; Zeng Y; Conway MJ; Mackett M; Arrand JR
Lancet; 1991 Mar; 337(8743):685-9. PubMed ID: 1672175
[TBL] [Abstract][Full Text] [Related]
5. Antibody to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma.
Chen JY; Liu MY; Lynn TC; Yang CS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Nov; 15(4):255-61. PubMed ID: 6305599
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
Bardy B; Morinet F; Pérol Y
Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to Epstein-Barr virus-specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma.
Tan RS; Cheng YC; Naegele RF; Henle W; Glaser R; Champion J
Int J Cancer; 1982 Nov; 30(5):561-5. PubMed ID: 6295964
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study.
Chen JY; Hwang LY; Beasley RP; Chien CS; Yang CS
J Med Virol; 1985 Jun; 16(2):99-105. PubMed ID: 2989423
[TBL] [Abstract][Full Text] [Related]
9. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
Zhu XX; Zeng Y; Wolf H
Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
[TBL] [Abstract][Full Text] [Related]
10. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan.
Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Beasley RP; Hwang LY
J Med Virol; 1989 Apr; 27(4):269-73. PubMed ID: 2542436
[TBL] [Abstract][Full Text] [Related]
11. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
Gurtsevich VE; Ruíz García R; Cuevas J; Le Riverand Morales E; Ascue M
Vopr Virusol; 1979; (4):392-9. PubMed ID: 225887
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
Hsu MM; Chen JY; Chen CJ
Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):984-8. PubMed ID: 2853721
[No Abstract] [Full Text] [Related]
13. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma.
Chen JY; Liu MY; Chen CJ; Hsu MM; Tu SM; Lee HH; Kuo SL; Yang CS
J Med Virol; 1985 Sep; 17(1):47-9. PubMed ID: 2995572
[TBL] [Abstract][Full Text] [Related]
14. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)].
Wilmes E; Wolf H; Deinhardt F; Naumann HH
Laryngol Rhinol Otol (Stuttg); 1979 Dec; 58(12):911-5. PubMed ID: 231716
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups.
Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Lee HH; Kuo SL
J Med Virol; 1987 Sep; 23(1):11-21. PubMed ID: 2824675
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
Cevenini R; Donati M; Caliceti U; Moroni A; Tamba I; Rumpianesi F
J Infect; 1986 Mar; 12(2):127-31. PubMed ID: 3009628
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
Ho HC; Ng MH; Kwan HC; Chau JC
Br J Cancer; 1976 Dec; 34(6):655-60. PubMed ID: 188437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
